364 related articles for article (PubMed ID: 23830224)
1. Nasopharyngeal carcinoma in children and adolescents in an endemic area: a report of 185 cases.
Yan Z; Xia L; Huang Y; Chen P; Jiang L; Zhang B
Int J Pediatr Otorhinolaryngol; 2013 Sep; 77(9):1454-60. PubMed ID: 23830224
[TBL] [Abstract][Full Text] [Related]
2. Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.
Xu P; Min Y; Blanchard P; Feng M; Zhang P; Luo Y; Fan Z; Lang J
Head Neck; 2017 Feb; 39(2):305-310. PubMed ID: 27627795
[TBL] [Abstract][Full Text] [Related]
3. [Prophylactic irradiation of cervical lymph nodes for Stage-N0 nasopharyngeal carcinoma].
Xie FY; Peng M; Hu WH; Han F; Wang X; Xu HM
Chin J Cancer; 2010 Jan; 29(1):106-10. PubMed ID: 20038321
[TBL] [Abstract][Full Text] [Related]
4. Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Cancer Center.
Xu BQ; Tu ZW; Tao YL; Liu ZG; Li XH; Yi W; Jiang CB; Xia YF
Chin J Cancer; 2016 Apr; 35():37. PubMed ID: 27056488
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
6. The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.
Ou X; Miao Y; Wang X; Ding J; He X; Hu C
Radiat Oncol; 2017 Aug; 12(1):137. PubMed ID: 28821277
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of residual or recurrent lymph nodes in the neck for patients with nasopharyngeal carcinoma after radiotherapy.
Wang M; Xu Y; Chen X; Chen H; Gong H; Chen S
J Cancer Res Ther; 2016; 12(2):909-14. PubMed ID: 27461673
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma.
Qiu WZ; Peng XS; Xia HQ; Huang PY; Guo X; Cao KJ
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1563-1572. PubMed ID: 28342002
[TBL] [Abstract][Full Text] [Related]
9. Long-term Outcomes Following Radiotherapy for Adolescent Patients With Nonmetastatic WHO Type III Nasopharyngeal Carcinoma.
Greenwalt JC; Indelicato DJ; Amdur RJ; Morris CG; Kirwan JM; Mendenhall WM
Am J Clin Oncol; 2016 Dec; 39(6):581-585. PubMed ID: 24937634
[TBL] [Abstract][Full Text] [Related]
10. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013.
Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y
Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219
[TBL] [Abstract][Full Text] [Related]
11. Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma.
Zeng L; Sun XM; Chen CY; Han F; Huang Y; Xiao WW; Liu S; Tian YM; Deng XW; Lu TX
Head Neck; 2014 May; 36(5):687-93. PubMed ID: 23606573
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and long-term outcomes of nasopharyngeal carcinoma in children and adolescents.
Hu S; Xu X; Xu J; Xu Q; Liu S
Pediatr Blood Cancer; 2013 Jul; 60(7):1122-7. PubMed ID: 23303571
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Outcomes of Nasopharyngeal Carcinoma in 148 Children and Adolescents.
Lu S; Chang H; Sun X; Zhen Z; Sun F; Zhu J; Wang J; Huang J; Liao R; Guo X; Lu L; Gao Y
Medicine (Baltimore); 2016 Apr; 95(17):e3445. PubMed ID: 27124036
[TBL] [Abstract][Full Text] [Related]
14. [A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma].
Mao YP; Li WF; Chen L; Sun Y; Liu LZ; Tang LL; Cao SM; Lin AH; Hong MH; Lu TX; Liu MZ; Li L; Ma J
Ai Zheng; 2009 Oct; 28(10):1022-8. PubMed ID: 19799808
[TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal carcinoma in children and adolescents - a single institution experience of 158 patients.
Liu W; Tang Y; Gao L; Huang X; Luo J; Zhang S; Wang K; Qu Y; Xiao J; Xu G; Yi J
Radiat Oncol; 2014 Dec; 9():274. PubMed ID: 25477058
[TBL] [Abstract][Full Text] [Related]
16. Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area.
Huang PY; Zeng Q; Cao KJ; Guo X; Guo L; Mo HY; Wu PH; Qian CN; Mai HQ; Hong MH
Eur J Cancer; 2015 Sep; 51(13):1760-70. PubMed ID: 26093812
[TBL] [Abstract][Full Text] [Related]
17. Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.
Kunheri B; Agarwal G; Sunil PS; Nair AR; Pushpaja KU
Indian J Cancer; 2017; 54(3):502-507. PubMed ID: 29798947
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
[TBL] [Abstract][Full Text] [Related]
19. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
20. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.
Chen L; Hu CS; Chen XZ; Hu GQ; Cheng ZB; Sun Y; Li WX; Chen YY; Xie FY; Liang SB; Chen Y; Xu TT; Li B; Long GX; Wang SY; Zheng BM; Guo Y; Sun Y; Mao YP; Tang LL; Chen YM; Liu MZ; Ma J
Lancet Oncol; 2012 Feb; 13(2):163-71. PubMed ID: 22154591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
